Rosalind Advisors, Inc. Hedge Fund

CIK: 0001622627 · Show all filings

Period: Q4 2023 (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $121,420 (100.0% shares, 0.0% debt)

Holdings (30)

LYRA THERAPEUTICS INC 8.2%
Value ($000) $9,897 Shares 1,888,720 Est. Cost $5.24 Unrealized
MYO MYOMO INC-NEW 7.9%
Value ($000) $9,619 Shares 1,919,910 Est. Cost $2.66 Unrealized 0.0%
ASTRIA THERAPEUTICS INC 7.1%
Value ($000) $8,668 Shares 1,128,708 Est. Cost $7.68 Unrealized
XERS XERIS BIOPHARMA HLDGS INC 6.9%
Value ($000) $8,328 Shares 3,543,685 Est. Cost $1.85 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 6.5%
Value ($000) $7,848 Shares 360,332 Est. Cost $15.79 Unrealized 0.0%
CMPS COMPASS PATHWAYS PLC ADR 5.8%
Value ($000) $6,987 Shares 798,500 Est. Cost $8.75 Unrealized
OPTINOSE INC 5.2%
Value ($000) $6,302 Shares 4,885,580 Est. Cost $1.29 Unrealized
MDWD MEDIWOUND LTD-NEW 5.1%
Value ($000) $6,171 Shares 606,751 Est. Cost $8.98 Unrealized 0.0%
MDGL MADRIGAL PHARMACEUTICALS 4.8%
Value ($000) $5,785 Shares 25,000 Est. Cost $174.99 Unrealized 0.0%
CELLECTAR BIOSCIENCES-NEW 4.6%
Value ($000) $5,556 Shares 2,005,658 Est. Cost $2.77 Unrealized
SRPT SAREPTA THEREAPEUTICS INC 4.6%
Value ($000) $5,535 Shares 57,400 Est. Cost $95.93 Unrealized 0.0%
VERONA PHARMA PLC SPN/ADR 4.1%
Value ($000) $4,970 Shares 250,000 Est. Cost $19.88 Unrealized
SPRUCE BIOSCIENCES INC 3.8%
Value ($000) $4,648 Shares 1,586,392 Est. Cost $2.93 Unrealized
PROF PROFOUND MEDICAL CORP-NEW 3.7%
Value ($000) $4,528 Shares 533,333 Est. Cost $9.50 Unrealized 0.0%
DCTH DELCATH SYSTEMS, INC. 3.6%
Value ($000) $4,322 Shares 1,038,828 Est. Cost $3.27 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS 3.0%
Value ($000) $3,675 Shares 300,000 Est. Cost $9.10 Unrealized 0.0%
VERU INC 2.4%
Value ($000) $2,880 Shares 4,000,000 Est. Cost $0.72 Unrealized
NSPR INSPIREMD INC-NEW 2.1%
Value ($000) $2,600 Shares 925,194 Est. Cost $2.88 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 2.1%
Value ($000) $2,496 Shares 1,862,425 Est. Cost $1.51 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S ADR 1.7%
Value ($000) $2,116 Shares 16,800 Est. Cost $125.95 Unrealized
FBIO FORTRESS BIOTECH INC-NEW 1.5%
Value ($000) $1,829 Shares 607,797 Est. Cost $2.64 Unrealized 0.0%
ENVVENO MEDICAL CORP 1.3%
Value ($000) $1,604 Shares 312,091 Est. Cost $5.14 Unrealized
RVPH REVIVA PHARMACEUTICALS 0.8%
Value ($000) $1,011 Shares 196,300 Est. Cost $4.49 Unrealized 0.0%
SAREPTA THERAPEUTICS INC 0.7%
Value ($000) $832 Shares 57,400 Est. Cost Unrealized
MERRIMACK PHARMACEUT-NEW 0.7%
Value ($000) $805 Shares 60,000 Est. Cost $13.41 Unrealized
INVESCO QQQ TR 0.5%
Value ($000) $602 Shares 900,000 Est. Cost Unrealized
TLPH ACELRX PHARMACEUTICAL-NEW 0.5%
Value ($000) $558 Shares 758,966 Est. Cost $0.64 Unrealized 0.0%
XBI SPDR SER TR 0.4%
Value ($000) $465 Shares 500,000 Est. Cost Unrealized
GERN GERON CORP 0.3%
Value ($000) $422 Shares 200,000 Est. Cost $1.94 Unrealized 0.0%
TONIX PHARMA HLDG CRP-NEW 0.3%
Value ($000) $363 Shares 900,900 Est. Cost $0.40 Unrealized